Key result
Beta-blocker use, amiodarone use, and paroxysmal atrial fibrillation were significant predictors of immediate sinus arrest after cardioversion.
Why the study?
Sinus arrest is a recognized but likely underreported complication of cardioversion with widely variable reported incidence, prompting investigation into risk factors that predict adverse outcomes.
What are the clinical predictors of immediate post-cardioversion sinus arrest in patients undergoing cardioversion?
Case-Control (n=12,156)
Yes
What are the clinical predictors of immediate post-cardioversion sinus arrest in patients undergoing cardioversion?
Paroxysmal atrial fibrillation, beta-blocker use, and amiodarone use are strong predictors of immediate sinus arrest following cardioversion, suggesting a need for careful risk stratification.
Answers are grounded in this paper and cite their sources.
Heightened post-cardioversion monitoring for sinus arrest is warranted; leaves open reliable predictors of adverse outcomes.
Introduction Sinus arrest remains a recognized but likely underreported complication of cardioversion, with incidence ranging widely in the literature, from virtually 0% to 1.5%. After a case of elective cardioversion resulting in the need for ECMO support, we investigated possible risk factors that could help predict adverse outcomes after cardioversion. Hypothesis Cardioversion, while generally benign, is not without risks, and further study may help elucidate predictors of morbidity and mortality. Methods We retrospectively reviewed data of all patients who underwent cardioversion at three hospitals within the Lifespan health system, Rhode Island Hospital, Newport Hospital, and the Miriam Hospital, between 2000 and 2015. 23 patients who experienced sinus arrest after cardioversion, and characteristics of these patients were compared with those of 3:1 age-and-gender matched controls using binomial logistic regression analysis on Stata. Results Of 12,156 patients who underwent cardioversion, 23 patients (57% male, mean age 78±14), or 0.18%, experienced immediate post-cardioversion sinus arrest, defined as absence of sinus activity for greater than five seconds. Compared with 3:1 age-and-gender-matched controls who underwent cardioversion without incident, binomial logistic regression revealed that paroxysmal atrial fibrillation (OR 11.8; 95% CI 1.85–75.72; p=0.009), beta-blocker use (OR 58.0; 95% CI 2.4–1404.48; p=0.013), Amiodarone use (OR 19.9; 95% CI 2.0–198.32; p=0.011), and elevated ventricular rate (CV 0.028; 95% CI 0.0031–0.053; p=0.027) were statistically significant predictors of sinus arrest after cardioversion. Calcium-channel blocker use, Digoxin use, age, gender, PR interval, QRS duration, and corrected QT interval were not significant associations. Conclusions Sparse data exists regarding characteristics predisposing patients to adverse outcomes following cardioversion, and further risk stratification is warranted, given the potential for significant morbidity and mortality. Our findings raise questions that demand elucidation, such as whether beta-blockers or Amiodarone should be held prior to cardioversion.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2019) conducted a case-control in Patients undergoing cardioversion (n=12,156). Beta-blocker use vs. No beta-blocker use was evaluated on Immediate post-cardioversion sinus arrest (absence of sinus activity for >5 seconds) (OR 58.0, 95% CI 2.4-1404.48, p=0.013). Beta-blocker use, amiodarone use, and paroxysmal atrial fibrillation were significant predictors of immediate sinus arrest after cardioversion.
Synapse has enriched 10 related papers. Consider them for comparative context: